2Niederman M S,Mandell L A,Anzueto A, et al. Guidelines for the management of adults with community acquired pneumoni- a. Diagnosis, assessment of severity, antimicrobial therapy, and prevention[J]. Am J Respir Crit Care Med, 2001, 163 (7) : 1730-1754.
4Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
5Lepow ML,Balassanian N,Emmerich J,et al.Interrelationships of viral,mycoplasmal,and bacterial agents in uncomplicated pneumonia.Am Rev Respir Dis,1968,97:533-545.
6Lim WS,Macfarlane JT,Boswell TC,et al.Study of community acquired pneumonia aetiology(SCAPA) in adults admitted to hospital:implications for management guidelines.Thorax,2001,56:296-301.
7Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia.Diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754.
8Heffelfinger JD,Dowell SF,Jorgensen JH,et al.Management of community-acquired pneumonia in the era of pneumococcal resistance:a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.Arch Intern Med,2000,160:1399-1408.
9[2]Coudron PE,moland ES,Thomoson KS.Occurence and detection of AmpC beta-Lactamases.Among Escherichia coli,Klebsielia Pneumoniae,and Proteus mirabilis isolates at a veterans medical center[J].J clin microbiol,2000,38:1791.
10[5]National Committee for Clinical Laboratory standards.performance standards for antimierobial disk susceptibility tests[S].6th ed.Approved MZA6 wayme:NCCLS,2003.
